ALGS vs NVDA · rev $3.6M vs P/E 58, rev $96.22B
Aligos Therapeutics Inc (ALGS) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
ALGS currently screens at market cap $44.1M. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the ALGS and NVDA stock pages for the full models.
Not investment advice.